Search
Skittish risk managers could turn Bitcoin’s institutional boom into a bust, CEO warns
12.11.2025
Markus Thielen warns Bitcoin’s institutional rally could reverse as ETF outflows and market fatigue weigh on risk appetite
Skittish risk managers could turn Bitcoin’s institutional boom into a bust, CEO warns
12.11.2025
Markus Thielen warns Bitcoin’s institutional rally could reverse as ETF outflows and market fatigue weigh on risk appetite
Skittish risk managers could turn Bitcoin’s institutional boom into a bust, CEO warns
12.11.2025
Markus Thielen warns Bitcoin’s institutional rally could reverse as ETF outflows and market fatigue weigh on risk appetite
Skittish risk managers could turn Bitcoin’s institutional boom into a bust, CEO warns
12.11.2025
Markus Thielen warns Bitcoin’s institutional rally could reverse as ETF outflows and market fatigue weigh on risk appetite
Skittish risk managers could turn Bitcoin’s institutional boom into bust, CEO warns
12.11.2025
Markus Thielen warns Bitcoin’s institutional rally could reverse as ETF outflows and market fatigue weigh on risk appetite
Skittish risk managers could turn Bitcoin’s institutional boom into bust, CEO warns
12.11.2025
Markus Thielen warns Bitcoin’s institutional rally could reverse as ETF outflows and market fatigue weigh on risk appetite
Skittish risk managers could turn Bitcoin’s institutional boom into bust, CEO warns
12.11.2025
Markus Thielen warns Bitcoin’s institutional rally could reverse as ETF outflows and market fatigue weigh on risk appetite
Skittish risk managers could turn Bitcoin’s institutional boom into bust, CEO warns
12.11.2025
Markus Thielen warns Bitcoin’s institutional rally could reverse as ETF outflows and market fatigue weigh on risk appetite
Skittish risk managers could turn Bitcoin’s institutional boom into bust, CEO warns
12.11.2025
Markus Thielen warns Bitcoin’s institutional rally could reverse as ETF outflows and market fatigue weigh on risk appetite
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token
Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
12.11.2025
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token